Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for prevention of cognitive impairment induced by electroconvulsive therapy
IRCT20180623040193N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of donepezil in confusion, sponsored by Shahrekord University of Medical Sciences. Started Jul 2017; status: completed.
02
Drugs
donepezil
03
Conditions
confusion
Beyond the preview
Go deeper on IRCT20180623040193N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180623040193N1.